☆ 4.7 Article

Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones

CHEMICAL COMMUNICATIONS (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Medicinal

Solubility-driven optimization of benzothiopyranone salts leading to a preclinical candidate with improved pharmacokinetic properties and activity against Mycobacterium tuberculosis

Peng Li et al.

Summary: Solubility-driven optimization of nitro benzothiopyranone 1 led to the synthesis of five pharmaceutically acceptable salts. These salts exhibited increased aqueous solubility and improved oral bioavailability compared to compound 1. The maleate salt 2 demonstrated higher chemical stability, lower log P, and a better in vivo effect, making it a promising preclinical candidate for treating tuberculosis.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Add to Collection

Review Pharmacology & Pharmacy

Advances in the design of combination therapies for the treatment of tuberculosis

Jonah Larkins-Ford et al.

Summary: This article discusses the methods and advances in designing drug combinations for tuberculosis, including in vitro, in vivo, and computational approaches. By using optimized combination therapies, utilizing existing and new drug combination backbones, novel and effective multidrug therapies can be generated.

EXPERT OPINION ON DRUG DISCOVERY (2023)

Add to Collection

Article Biochemical Research Methods

Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine

Vincent Desfontaine et al.

Summary: Tuberculosis, especially multidrug-resistant tuberculosis, is a global health threat. Macozinone is a potential candidate for the treatment of drug-resistant Mycobacterium tuberculosis. A LC-MS/MS method was developed for the analysis of plasma samples to support clinical trials of macozinone. The optimization of the method allowed the identification of new metabolites, including H2PBTZ, and these methods were successfully applied in a clinical trial.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2023)

Add to Collection

Letter Infectious Diseases

Pretomanid-resistant tuberculosis

Niklas Koehler et al.

JOURNAL OF INFECTION (2023)

Add to Collection

Article Microbiology

Antituberculosis Macozinone Extended-Release Tablets To Enhance Bioavailability: a Pilot Pharmacokinetic Study in Beagle Dogs

Angela Koryakova et al.

Summary: This study evaluated the pharmacokinetics of Macozinone (MCZ) in different formulations. The results showed that extended-release tablets significantly increased the bioavailability of MCZ compared to dispersible tablets, potentially improving treatment adherence and reducing the development of drug resistance.

MICROBIOLOGY SPECTRUM (2023)

Add to Collection

Article Chemistry, Physical

Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions

Tejas M. Dhameliya et al.

Summary: Tuberculosis is a highly chronic and contagious disease caused by Mycobacterium tuberculosis, with current treatment methods failing due to drug resistance. In recent years, research has focused on developing new drugs to combat resistance, using techniques such as molecular docking and 3D-QSAR to design novel anti-TB agents.

JOURNAL OF MOLECULAR STRUCTURE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex

Jose Camilla Sammartino et al.

Summary: This study aims to describe the relationship between the tuberculosis drug targets DprE1 and DprE2, demonstrating that their co-expression improves enzymatic catalytic properties. The findings lay the foundation for structural studies and the development of more specific inhibitors to combat drug-resistant strains.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Add to Collection

Article Microbiology

Identification of Mutations Associated With Macozinone-Resistant in Mycobacterium Tuberculosis

Xi Chen et al.

Summary: This study identified drug-resistant mutations to the anti-tuberculosis drug MCZ through in vitro resistance selection. The mutation of C387S in the dprE1 gene was found to be directly related to high-level MCZ resistance. Additionally, low concentrations of MCZ can induce high-level drug resistance. New mutations in the dprE1 gene were also discovered, along with other gene mutations associated with drug efflux or membrane permeability.

CURRENT MICROBIOLOGY (2022)

Add to Collection

Article Chemistry, Medicinal

Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones

Sebastian Schieferdecker et al.

Summary: In this study, a set of BTZs were synthesized and evaluated for their antimycobacterial activity. High potency was achieved through piperidine and piperazine substitutions, and promising candidates were identified. It was found that target inhibition is not the only requirement for suitable antimycobacterial agents. Extensively validated machine learning models successfully predicted whole cell activity class.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Chemistry, Medicinal

Tuberculosis Drug Discovery: Challenges and New Horizons

Guilherme F. S. Fernandes et al.

Summary: Tuberculosis (TB) has taken more lives than any other infectious disease in the past 2000 years. Despite the comparable death toll with COVID-19 in 2020, the World Health Organization emphasizes the need for new TB drugs to end this pandemic. However, only a small fraction of the promising anti-TB compounds reported annually successfully reach clinical development.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Review Microbiology

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

Veronique A. Dartois et al.

Summary: Despite two decades of research, uncertainties in understanding and curing tuberculosis disease continue to hinder progress. However, collaborative efforts between academia, the pharmaceutical industry, and non-profit organizations have resulted in a promising drug candidate pipeline. This review explores the challenges and benefits of standardized regimens versus individualized therapy and highlights the need for markers of disease progression, drug response, and predictors of relapse, as well as in vitro tools and animal models for evaluating new regimens. Additionally, it discusses the importance of prioritizing drug combinations for clinical trials and redesigning trial designs to expedite regimen development.

NATURE REVIEWS MICROBIOLOGY (2022)

Add to Collection

Article Chemistry, Medicinal

Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents

Rui Shi et al.

Summary: This study found that by introducing a methanesulfonyl substituent at the 6-position, the physicochemical properties of 8-nitrobenzothiazinone derivatives (BTZs) can be improved, leading to increased aqueous solubility and metabolic stability. Among these derivatives, MsPBTZ169 and compounds 2 and 8 showed low minimum inhibitory concentrations (MICs), indicating high antitubercular activity.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Add to Collection

Article Critical Care Medicine

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

Keertan Dheda et al.

Summary: The global burden of tuberculosis remains high, but the COVID-19 pandemic has had a detrimental effect on tuberculosis control. This article explores the intersection between tuberculosis and COVID-19, discusses the impact of COVID-19 on tuberculosis detection, morbidity, and mortality at both population and patient levels, proposes strategies to mitigate the effects of COVID-19, and highlights research priorities and challenges in restoring the global response to tuberculosis.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection

Review Microbiology

Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis

Xinyue Xu et al.

Summary: The dynamic cell envelope of Mycobacterium tuberculosis regulates the immune response and is a crucial target for drug and vaccine development.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Chemistry, Medicinal

BTZ-Derived Benzisothiazolinones with In Vitro Activity against Mycobacterium tuberculosis

Adrian Richter et al.

Summary: Two BTZ043-derived benzisothiazolinones (BITs) with antimycobacterial activity were reported, confirming their molecular structures. In contrast, O-acyl benzisothiazol-3-ols, which are constitutionally isomeric, showed little or no antimycobacterial activity in vitro.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Add to Collection

Article Crystallography

Structural characterization of the azoxy derivative of an antitubercular 8-nitro-1,3-benzothiazin-4-one

Adrian Richter et al.

Summary: The structure of a new compound was successfully synthesized and determined. X-ray crystallography revealed that the compound is composed of two benzothiazinone moieties linked by a Z-configured azoxy group, forming a densely packed herringbone pattern in the crystal.

ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS (2022)

Add to Collection

Article

DprE1 inhibitors – a prospective target for development of antituberculosis drugs

A. V. Kukurika

Tuberculosis and Lung Diseases (2022)

Add to Collection

Review Public, Environmental & Occupational Health

An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis

Mohd Imran et al.

Summary: This article reviews the discovery, development, clinical studies, and patents of macozinone (MCZ) as an antituberculosis drug, and discusses the combination of MCZ with other drugs. The research findings suggest that MCZ is a promising DprE1 inhibitor that could help tackle drug resistance, and anticipate the development of new combinations, salts, and polymorphs of MCZ.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2022)

Add to Collection

Review Chemistry, Multidisciplinary

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties

Patricia S. M. Amado et al.

Summary: DprE1 is a critical enzyme in Mycobacterium tuberculosis, and the design and optimization of its inhibitors are important for the development of improved drugs for tuberculosis.

ACS OMEGA (2022)

Add to Collection

Review Pharmacology & Pharmacy

The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis

Brett D. Edwards et al.

Summary: This article provides a comprehensive review of the current pipeline of treatments for tuberculosis, including multidrug-resistant strains. The review categorizes each compound by its site of activity and discusses both established drugs and upcoming molecules. It aims to provide a clinically applicable understanding of the most relevant compounds, including those under clinical study and those showing promising pre-clinical results. The article also extensively reviews the efficacy and safety data of contemporary drugs already incorporated into treatment regimens. It highlights important compounds targeting different levels of the bacterial cell wall, as well as new and exciting prospective agents with novel mechanisms of impact against TB.

DRUGS (2022)

Add to Collection

Article Chemistry, Physical

Structural elucidation of the antitubercular benzothiazinone BTZ043: A combined X-ray, variable temperature NMR and DFT study

Adrian Richter et al.

Summary: The study reports the crystal structure of a chiral compound BTZ043, which is a potential antitubercular drug candidate, and analyzes its molecular conformation and rotational barrier. The results show that the rotation of this compound is influenced by two barriers.

JOURNAL OF MOLECULAR STRUCTURE (2022)

Add to Collection

Editorial Material Immunology

Multidrug Resistant Tuberculosis With Simultaneously Acquired Drug Resistance to Bedaquiline and Delamanid

Takashi Yoshiyama et al.

Summary: This study reported a clinical case of simultaneous acquisition of resistance to bedaquiline and delamanid in Mycobacterium tuberculosis, with specific nucleotide insertions identified through whole genome sequencing. The minimum inhibitory concentrations for bedaquiline and delamanid were determined to be 0.25 μg/mL and >2.0 μg/mL, respectively.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article

Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone

V. G. Nesterenko et al.

Drug Development and Registration (2021)

Add to Collection

Article Chemistry, Medicinal

8-cyanobenzothiazinone analogs with potent antitubercular activity

Gang Zhang et al.

Summary: This study introduced a new class of antitubercular agents, 8-cyanobenzothiazinone, as a potential replacement for the aryl nitro group in 8-nitrobenzothiazinones, showing potent activity and improved pharmacokinetic properties. The results suggest that the nitro group in benzothiazinones can be successfully replaced with a nitrile to maintain useful activity and favorable pharmacokinetic properties.

MEDICINAL CHEMISTRY RESEARCH (2021)

Add to Collection

Article Chemistry, Medicinal

Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents

Dongguang Fan et al.

Summary: By designing and synthesizing a series of 6-methanesulfonyl substituted BTZ analogues and introducing five-member aromatic heterocycles as linkers, we discovered a number of BTZ derived compounds with potent antitubercular activity, with two optimized compounds exhibiting increased aqueous solubility and stability.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Medicine, Research & Experimental

Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs

Aditi Chauhan et al.

Summary: Tuberculosis is one of the deadliest infectious diseases with serious global threat, as the high drug resistance of Mycobacterium tuberculosis leads to increasing number of cases each year. Available antimycobacterial drugs are classified into first line, second line, and third line antibiotics, but years of non-judicious and uncontrolled use have created the significant problem of multidrug-resistant tuberculosis (MDR). Research focuses on new drug candidates, repurposed drugs, and drug combinations for more effective treatment of MDR tuberculosis or reducing chemotherapy time for drug sensitive TB.

LIFE SCIENCES (2021)

Add to Collection

Article Chemistry, Medicinal

Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains

Akanksha Sharma et al.

Summary: This review provides an overview of the important progress in tuberculosis treatment over the past decade, including the increasing incidences of multidrug-resistant and extensively drug-resistant tuberculosis, as well as various strategies to address these issues. Additionally, it discusses the role of pathogen-host immune mechanisms in disease prevention, as well as the challenges and efforts in developing novel drug therapies.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Microbiology

From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis

Leah Isobella Rankine-Wilson et al.

Summary: Tuberculosis, caused by Mycobacterium tuberculosis, is a serious disease that requires lengthy and complicated treatment. Understanding the physiological mechanisms of Mtb can lead to the development of more effective drug therapies.

MICROBIOLOGY-SGM (2021)

Add to Collection

Article Microbiology

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832

Gregory T. Robertson et al.

Summary: The study evaluated the efficacy of three DprE1 inhibitors in a mouse tuberculosis model, showing significant effects after 2 months of treatment. OPC-167832 demonstrated superior efficacy at low dose levels, possibly due to its low MIC, favorable distribution, and sustained retention in lesion tissue.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Add to Collection

Article Chemistry, Medicinal

Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis

Apeng Wang et al.

Summary: A series of novel benzothiazinone derivatives containing a N-(amino)piperazine moiety, based on the structure of WAP-1902 discovered in the lab, were designed and synthesized as new anti-TB agents. Many compounds showed excellent in vitro activity against drug-sensitive MTB strain H37Rv and multidrug-resistant clinical isolates, with good safety index. Compound 1o, in particular, displayed low hERG cardiac toxicity and acceptable oral pharmacokinetic profiles, indicating its potential as a lead compound for future antitubercular drug discovery.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Chemistry, Multidisciplinary

A Call for Increased Focus on Reproductive Health within Lab Safety Culture

Catherine P. McGeough et al.

Summary: The approach to reproductive health and safety in academic laboratories needs more attention and a paradigm shift, with current practices often placing the burden on pregnant or planning-to-conceive individuals, leading to inconsistencies and confusion. To promote safer and more inclusive laboratory environments, consistent and clear information about reproductive health should be provided to laboratory researchers, and discussions about reproductive health should be normalized among all researchers.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Add to Collection

Article Chemistry, Medicinal

Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones

Balungile Madikizela et al.

Summary: The study reports on the limited effectiveness of halogenated nitro-free BTZs against tuberculosis, suggesting that further investigation in this direction may not be a promising approach.

MEDICINAL CHEMISTRY RESEARCH (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence

Sonali Chhabra et al.

Summary: This study delves into the chemogenomic space of DprE1 inhibitors, revealing their lipophilic character and biological activity against the disease, providing crucial insights for the discovery of novel drug targets for Mycobacterium tuberculosis.

ACS OMEGA (2021)

Add to Collection

Article Crystallography

2-Chloro-3-nitro-5-(trifluoromethyl)benzoic acid and -benzamide: structural characterization of two precursors for antitubercular benzothiazinones

Adrian Richter et al.

Summary: 8-Nitro-1,3-benzothiazin-4-ones are a promising class of new antitubercular agents, with two candidates, BTZ043 and PBTZ169, having reached clinical trials. The crystal and molecular structures of two synthetic precursors, 2-chloro-3-nitro-5-(trifluoromethyl)benzoic acid and 2-chloro-3-nitro-5-(trifluoromethyl)benzamide, are reported, showing significant twists in the carboxy, carboxamide, and nitro groups out of the benzene ring plane.

ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS (2021)

Add to Collection

Review Microbiology

The mycobacterial cell envelope - a moving target

Charles L. Dulberger et al.

NATURE REVIEWS MICROBIOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system

Sarah M. Batt et al.

BIOCHEMICAL JOURNAL (2020)

Add to Collection

Review Medical Laboratory Technology

New tuberculosis drug targets, their inhibitors, and potential therapeutic impact

Gauri S. Shetye et al.

TRANSLATIONAL RESEARCH (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Development of Macozinone for TB treatment: An Update

Vadim Makarov et al.

APPLIED SCIENCES-BASEL (2020)

Add to Collection

Article Chemistry, Medicinal

Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro [3.5]nonane moieties as new antitubercular agents

Apeng Wang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Crystallographic evidence for unintended benzisothiazolinone 1-oxide formation from benzothiazinones through oxidation

Tamira Eckhardt et al.

ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2020)

Add to Collection

Article Chemistry, Medicinal

Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents

Lingfeng Liu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Chemistry, Multidisciplinary

In vitro and in vivo antitubercular activity of benzothiazinone-loaded human serum albumin nanocarriers designed for inhalation

Ayasha Patel et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Molecular Insight into the Discrepancy of Antitubercular Activity between 8-Nitro and 8-Cyano Benzothiazinones

Gang Zhang et al.

CHEMISTRYSELECT (2020)

Add to Collection

Article Medicine, Research & Experimental

In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis

Shaochen Guo et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Article Crystallography

[2-Chloro-3-nitro-5-(trifluoromethyl)phenyl](piper-idin-1-yl)methanone: structural characterization of a side product in benzothiazinone synthesis

Tamira Eckhardt et al.

ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS (2020)

Add to Collection

Review Chemistry, Multidisciplinary

The Chalcogen Bond in Crystalline Solids: A World Parallel to Halogen Bond

Patrick Scilabra et al.

ACCOUNTS OF CHEMICAL RESEARCH (2019)

Add to Collection

Article Chemistry, Inorganic & Nuclear

SYNTHESIS AND ANTITUBERCULAR EVALUATION OF FLUORINATED 2-CYCLOALKYLIMINO SUBSTITUTED 1,3-BENZOTHIAZIN-4-ONES

Emiliya V. Nosova et al.

JOURNAL OF FLUORINE CHEMISTRY (2019)

Add to Collection

Article Chemistry, Organic

Synthesis of Fluorine-Containing 2-Pyrrolyl- and 2-Indolyl-Substituted 1,3-Benzothiazin-4-ones

E. V. Nosova et al.

RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (2019)

Add to Collection

Review Respiratory System

The global prevalence of latent tuberculosis: a systematic review and meta-analysis

Adam Cohen et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Multidisciplinary Sciences

Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma

Deny Spaggiari et al.

PLOS ONE (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Macozinone: revised synthesis and crystal structure of a promising new drug for treating drug-sensitive and drug-resistant tuberculosis

Gang Zhang et al.

ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2019)

Add to Collection

Article Medicine, General & Internal

Management of drug-resistant tuberculosis

Christoph Lange et al.

LANCET (2019)

Add to Collection

Article Chemistry, Medicinal

Deuteration of BTZ043 Extends the Lifetime of Meisenheimer Intermediates to the Antituberculosis Nitroso Oxidation State

Rui Liu et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

Add to Collection

Article Chemistry, Medicinal

Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents

Apeng Wang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Respiratory System

New Drugs for the Treatment of Tuberculosis

Elisa H. Ignatius et al.

CLINICS IN CHEST MEDICINE (2019)

Add to Collection

Article Chemistry, Medicinal

Nitro-Group-Containing Drugs

Kunal Nepali et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Review Chemistry, Medicinal

Synthesis and Biological Activity of 2-Amino- and 2-Aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones

Emiliya Nosova et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Microbiology

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis

Jeremie Piton et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Add to Collection

Article Chemistry, Medicinal

Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis

Rupesh V. Chikhale et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Review Respiratory System

Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment

Christoph Lange et al.

RESPIROLOGY (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles

Lu Xiong et al.

RSC ADVANCES (2018)

Add to Collection

Article Microbiology

Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)

Andreanne Lupien et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Add to Collection

Article Chemistry, Medicinal

Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones

Peng Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Multidisciplinary Sciences

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1

Adrian Richter et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Article Chemistry, Multidisciplinary

NMR-based investigations of acyl-functionalized piperazines concerning their conformational behavior in solution

Robert Wodtke et al.

RSC ADVANCES (2018)

Add to Collection

Article Chemistry, Medicinal

Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents

Kai Lv et al.

ACS MEDICINAL CHEMISTRY LETTERS (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Design, synthesis and antitubercular evaluation of benzothiazinones containing an oximido or amino nitrogen heterocycle moiety

Rui Zhang et al.

RSC ADVANCES (2017)

Add to Collection

Article Medicine, Research & Experimental

A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine models

Chao Gao et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Add to Collection

Article Chemistry, Multidisciplinary

In Vivo Dearomatization of the Potent Antituberculosis Agent BTZ043 via Meisenheimer Complex Formation

Florian Kloss et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)

Add to Collection

Article Critical Care Medicine

Delamanid and Bedaquiline Resistance inMycobacterium tuberculosisAncestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee

Harald Hoffmann et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Add to Collection

Article Microbiology

Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis

Caroline Shi-Yan Foo et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Add to Collection

Review Chemistry, Organic

Review About the Synthesis of 1,3-Benzothiazinone Derivatives

Shanshan Li et al.

CHINESE JOURNAL OF ORGANIC CHEMISTRY (2016)

Add to Collection

Article Chemistry, Medicinal

Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043

Rohit Tiwari et al.

ACS MEDICINAL CHEMISTRY LETTERS (2016)

Add to Collection

Article Chemistry, Multidisciplinary

The Cambridge Structural Database

Colin R. Groom et al.

ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS (2016)

Add to Collection

Article Multidisciplinary Sciences

Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis

Chao Gao et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Biochemistry & Molecular Biology

DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization

Miroslav Brecik et al.

ACS CHEMICAL BIOLOGY (2015)

Add to Collection

Article Microbiology

The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis

Vadim Makarov et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Add to Collection

Article Chemistry, Medicinal

Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives

Cui-Ting Peng et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Add to Collection

Article Infectious Diseases

In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis

Norma Alejandra Gonzalez-Martinez et al.

PLOS NEGLECTED TROPICAL DISEASES (2015)

Add to Collection

Review Medicine, General & Internal

Totally drug-resistant tuberculosis and adjunct therapies

S. K. Parida et al.

JOURNAL OF INTERNAL MEDICINE (2015)

Add to Collection

Article Chemistry, Medicinal

Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043

Rohit Tiwari et al.

ACS MEDICINAL CHEMISTRY LETTERS (2015)

Add to Collection

Article Pharmacology & Pharmacy

DprE1 - from the Discovery to the Promising Tuberculosis Drug Target

Katarina Miku.sova et al.

CURRENT PHARMACEUTICAL DESIGN (2014)

Add to Collection

Article Medicine, Research & Experimental

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Vadim Makarov et al.

EMBO MOLECULAR MEDICINE (2014)

Add to Collection

Article Chemistry, Medicinal

Design and Syntheses of Anti-Tuberculosis Agents Inspired by BTZ043 Using a Scaffold Simplification Strategy

Rohit Tiwari et al.

ACS MEDICINAL CHEMISTRY LETTERS (2014)

Add to Collection

Article Chemistry, Medicinal

Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents

Chao Gao et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Add to Collection

Article Chemistry, Multidisciplinary

Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents

Rohit Tiwari et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)

Add to Collection

Article Microbiology

In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis

Benoit Lechartier et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Add to Collection

Article Chemistry, Medicinal

Identification of Antitubercular Benzothiazinone Compounds by Ligand-Based Design

Tomislav Karoli et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Add to Collection

Article Chemistry, Multidisciplinary

Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-D-ribofuranose 2′-Oxidase DprE1

Claudia Trefzer et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors

Sarah M. Batt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Add to Collection

Article Cell Biology

Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis

Joao Neres et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Add to Collection

Article Microbiology

Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals Are Uniformly Susceptible to Benzothiazinones

Maria Rosalia Pasca et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Add to Collection

Article Chemistry, Multidisciplinary

Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-D-ribose 2′-epimerase DprE1 of Mycobacterium tuberculosis

Claudia Trefzer et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance

Giulia Manina et al.

MOLECULAR MICROBIOLOGY (2010)

Add to Collection

Article Critical Care Medicine

Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran

Ali Akbar Velayati et al.

CHEST (2009)

Add to Collection

Article Multidisciplinary Sciences

Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis

Vadim Makarov et al.

SCIENCE (2009)

Add to Collection

Article Microbiology

High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors

Thierry Christophe et al.

PLOS PATHOGENS (2009)

Add to Collection

Article Infectious Diseases

Synthesis and antileprosy activity of some dialkyldithiocarbamates

Vadim Makarov et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)

Add to Collection

Article Chemistry, Applied

Scale-up and safety evaluation of a Sandmeyer reaction

MA Nielsen et al.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.